Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep
apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Rationale: Obstructive sleep apnea (OSA) is linked to increased cardiovascular risk, but the
impact of mild forms of OSA and their treatment on cardiovascular outcomes remains …

Importance More than 70% of patients with resistant hypertension have obstructive sleep
apnea (OSA). However, there is little evidence about the effect of continuous positive airway …

Background Obesity and obstructive sleep apnea tend to coexist and are associated with
inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal …

Obstructive sleep apnoea (OSA), characterized by recurrent periods of upper airway
obstruction and intermittent hypoxaemia, is prevalent in patients with cardiovascular disease …

Context Systemic hypertension is prevalent among patients with obstructive sleep apnea
(OSA). Short-term studies indicate that continuous positive airway pressure (CPAP) therapy …

Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …

Background Continuous positive airway pressure (CPAP) in patients with obstructive sleep
apnea syndrome (OSAS) might lower blood pressure, but evidence from clinical studies is …

Abstract Purpose of Review Given the rising prevalence of obstructive sleep apnea (OSA),
we aimed to review the epidemiologic and pathophysiologic relationship of OSA …